Table 3.
Patient characteristics of study population 3: the cardiac tissue cohort.
| Variable | Value |
|---|---|
| Age, years | 68 ± 10 |
| Gender, male | 24 (75%) |
| SBP, mmHg | 136 ± 7 |
| DBP, mmHg | 81 ± 7 |
| BMI, kg/m2 | 27 ± 3 |
| BNP, pg/ml | 40 (15:109) |
| Medical history | |
| Atrial Fibrillation | 8 (25%) |
| Diabetes Mellitus | 6 (19%) |
| Smoking History | 11 (33%) |
| Hypercholesterolemia | 8 (25%) |
| Ischemic Heart Disease | 23 (70%) |
| Valvular Heart Disease | 16 (50%) |
| Hypertension | 12 (38%) |
| Medications | |
| RAAS Inhibitor | 15 (47%) |
| Βeta-Blocker | 21 (64%) |
| Statin | 18 (56%) |
| Loop diuretic | 12 (38%) |
| Calcium channel blocker | 4 (13%) |
| Echocardiography | |
| EF, % | 57 ± 7 |
| LVIDd, mm | 52.6 ± 5.7 |
| IVS, mm | 9.7 ± 1.5 |
| PW, mm | 10.9 ± 1.7 |
| E/e’ | 9.3 ± 2.6 |
| LAVI, mls/m2 | 28.8 ± 3.6 |
Values are mean ± SD, mean (25th:75th percentiles) or n (%). SBP/DBP, systolic and diastolic blood pressure; BMI, body mass index; RAAS Inhibitor, renin angiotensin system inhibitor; EF, ejection fraction; LVIDd, left ventricular end diastolic dimension; IVS, intraventricular septum; PW, posterior wall; E/e′, ratio of mitral early diastolic flow velocity over tissue Doppler lateral mitral annular lengthening velocity; LAVI, left atrial volume index.